Clinical Trials Directory

Trials / Unknown

UnknownNCT04283110

Impact of Adding Midzolam to Bupavicaine 0.5% in Regional Spinal Anaesthesia on Maternal Middle Cerebral Artery Velocimetry in Parturients With Severer Preeclampsia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Minia University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Trial to use GABA mimetic action of midazolam to ameliorate the severe preeclampsia induced neuronal excitotoxicity using middle cerebral artery transcranial doppler resisitive vasculer indices to evaluate . Secondery goal is to study end organ injury

Conditions

Interventions

TypeNameDescription
DRUGintrthecl midazolammidazolm as as adjuvant in spinal anesthesia

Timeline

Start date
2019-01-12
Primary completion
2020-02-17
Completion
2020-04-05
First posted
2020-02-25
Last updated
2020-02-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04283110. Inclusion in this directory is not an endorsement.

Impact of Adding Midzolam to Bupavicaine 0.5% in Regional Spinal Anaesthesia on Maternal Middle Cerebral Artery Velocime (NCT04283110) · Clinical Trials Directory